Press Releases August 3, 2026 08:00 AM

Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call

Mesa Laboratories Announces Q1 Fiscal 2027 Earnings Release and First Earnings Call

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
MLAB

Mesa Laboratories, Inc., a Nasdaq-listed company specializing in life science tools and quality control solutions, will announce its first quarter fiscal 2027 financial results on August 10, 2026, after market close. The company also plans to hold its inaugural earnings conference call on the same day to discuss financial details and answer analysts' questions.

Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call
MLAB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Mesa Laboratories is a global leader in life science tools and critical quality control solutions for regulated sectors such as pharmaceuticals, healthcare, and medical devices.
  • The company will report Q1 FY2027 financial results on August 10, 2026, followed by its first earnings conference call to engage with analysts.
  • Mesa's products focus on ensuring product integrity, and enhancing patient and worker safety across healthcare and pharmaceutical sectors.

LAKEWOOD, Colo., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced it will release financial results for its first fiscal quarter (“1Q27”) ended June 30, 2026 following market close on Monday, August 10, 2026. The Company will also hold its first earnings conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.

Details for the conference call can be found below:

Date:Monday, August 10, 2026Time:4:30 p.m. Eastern TimeToll Free:1-877-407-4018International:1-201-689-8471Conference ID:13761713Call me™ Link: https://callme.viavid.com/viavid/?callme=true&passcode=13761713&h=true&info=company-email&r=true&B=6
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1769592&tp_key=620296632d


Please call the conference telephone number or log on to the web access link five minutes prior to the start time.

A replay of the call will remain available for 45 days via the investors section of the Mesa Labs website at https://investors.mesalabs.com/.


About Mesa Laboratories, Inc.

Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.


CONTACT

John Sakys, CFO
Mesa Laboratories, Inc.
+1-303-987-8000
[email protected]

For more information about the Company, please visit its website at www.mesalabs.com


Risks

  • Financial results could be impacted by regulatory changes or challenges in the pharmaceutical and healthcare industries.
  • Market conditions and operational performance during the quarter may introduce earnings volatility or uncertainty.
  • Competition within the life sciences tools and quality control solutions market could affect Mesa's growth and profitability.

More from Press Releases

Golar LNG announces a new $600 million senior secured Revolving Credit Facility Aug 3, 2026 Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance Aug 3, 2026 Horse Racing’s Biggest Events Unite in Landmark New “Thoroughbred Championship Series” Aug 3, 2026 Amaze Holdings Announces Leadership Transition Aug 3, 2026 SEALSQ Highlights Growing Importance of Hardware-Based Crypto-Agility as AI Accelerates Cryptanalysis Aug 3, 2026